Tianjin Benefo Tejing Electric Co., Ltd. (SHA:600468)

Intra-Cellular Therapies Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,860	1,871	1,953	2,160	2,250	2,175
Other Revenue	91.2	91.2	82.05	73.1	89.85	24.84
Revenue	1,951	1,962	2,035	2,233	2,340	2,199
Revenue Growth (YoY)	-4.41%	-3.60%	-8.86%	-4.56%	6.38%	40.16%
Cost of Revenue	1,498	1,504	1,505	1,664	1,762	1,652
Gross Profit	452.97	458.13	529.79	569.38	577.65	547.39
Selling, General & Admin	277.41	272.08	267.73	287.94	318.49	285.6
Research & Development	100.93	101.97	113.1	123.91	103.62	87.59
Other Operating Expenses	-5.26	-6.96	5.04	19.84	5.83	7.88
Operating Expenses	374.22	370.45	401.6	444.3	433.85	397.65
Operating Income	78.75	87.68	128.19	125.08	143.79	149.74
Interest Expense	-14.47	-14.53	-19.32	-17.18	-20.74	-16.38
Interest & Investment Income	46.42	47.14	41.23	27.16	12.8	17.3
Currency Exchange Gain (Loss)	1.21	1.21	3.56	4.55	-3.16	0.52
Other Non Operating Income (Expenses)	-1.07	-1.75	-4.61	-2.33	-0.47	-1.35
EBT Excluding Unusual Items	113.75	119.74	149.04	137.27	132.22	149.82
Impairment of Goodwill	-217.29	-217.29	-10.19	-	-	-5.02
Gain (Loss) on Sale of Assets	-0.15	-0.22	-0.24	0.33	-1.07	-0.35
Asset Writedown	-0.29	-0.29	-0.02	-	-	-
Other Unusual Items	11.61	11.61	11.81	16.23	14.27	15.66
Pretax Income	-92.37	-86.46	150.4	153.84	145.42	160.11
Income Tax Expense	12.64	14.55	21.72	19.18	24.29	31.52
Earnings From Continuing Operations	-105.01	-101.01	128.68	134.66	121.12	128.59
Minority Interest in Earnings	-7.23	-8.43	-9.88	-13.69	-16.41	-18.62
Net Income	-112.24	-109.44	118.79	120.98	104.71	109.97
Net Income to Common	-112.24	-109.44	118.79	120.98	104.71	109.97
Net Income Growth	-	-	-1.80%	15.53%	-4.78%	95.30%
Shares Outstanding (Basic)	1,088	1,088	1,088	1,088	1,087	1,088
Shares Outstanding (Diluted)	1,088	1,088	1,088	1,088	1,087	1,088
Shares Change (YoY)	0.01%	0.01%	-0.01%	0.05%	-0.04%	-0.32%
EPS (Basic)	-0.10	-0.10	0.11	0.11	0.10	0.10
EPS (Diluted)	-0.10	-0.10	0.11	0.11	0.10	0.10
EPS Growth	-	-	-1.80%	15.47%	-4.75%	95.93%
Free Cash Flow	96.13	131.22	169.25	109.59	140.75	122.84
Free Cash Flow Per Share	0.09	0.12	0.16	0.10	0.13	0.11
Dividend Per Share	-	-	0.033	0.034	0.029	0.031
Dividend Growth	-	-	-2.94%	17.24%	-6.45%	-
Gross Margin	23.21%	23.35%	26.03%	25.50%	24.69%	24.89%
Operating Margin	4.04%	4.47%	6.30%	5.60%	6.15%	6.81%
Profit Margin	-5.75%	-5.58%	5.84%	5.42%	4.48%	5.00%
Free Cash Flow Margin	4.93%	6.69%	8.32%	4.91%	6.02%	5.58%
EBITDA	136.13	145.26	186.56	184.82	207.34	212.76
EBITDA Margin	6.98%	7.40%	9.17%	8.28%	8.86%	9.67%
D&A For EBITDA	57.38	57.58	58.37	59.74	63.55	63.01
EBIT	78.75	87.68	128.19	125.08	143.79	149.74
EBIT Margin	4.04%	4.47%	6.30%	5.60%	6.15%	6.81%
Effective Tax Rate	-	-	14.44%	12.47%	16.71%	19.69%
Revenue as Reported	1,951	1,962	2,035	2,233	2,340	2,199
Advertising Expenses	-	0.32	0.22	0.1	0.56	0.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.